# A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus

> **NCT06988553** · PHASE1 · COMPLETED · sponsor: **Eccogene** · enrollment: 45 (actual)

## Conditions studied

- Obesity or Overweight
- Type 2 Diabetes

## Interventions

- **DRUG:** AZD5004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06988553
- **Lead sponsor:** Eccogene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-17
- **Primary completion:** 2025-11-28
- **Final completion:** 2025-11-28
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06988553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06988553, "A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06988553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*